Global Neurotechnology Device Market Growth 2023-2029

Global Neurotechnology Device Market Growth 2023-2029

The global Neurotechnology Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Neurotechnology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurotechnology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurotechnology Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurotechnology Device players cover Abbott Laboratories, Advanced Bionics, Axonics Modulation Technologies, Boston Scientific Corp, Laborie, Cleveland Medical Devices, EndoStim, LivaNova and Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Neurotechnology is any technology that has a fundamental influence on how people understand the brain and various aspects of consciousness, thought, and higher order activities in the brain. It also includes technologies that are designed to improve and repair brain function and allow researchers and clinicians to visualize the brain. The digital health sector matures from basic tracking apps into highly regulated medical devices, right now there is a bleeding edge technologies being developed that blur the lines between computers and biology and a growing share of these startups are beginning to target the brain. The burgeoning field of neurotechnology involves brain-machine interfaces, neuroproteins, neurostimulation, neuromonitoring, and implantable devices intended to not only augment nervous system activity, but expand its capabilities.

LPI (LP Information)' newest research report, the “Neurotechnology Device Industry Forecast” looks at past sales and reviews total world Neurotechnology Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurotechnology Device sales for 2023 through 2029. With Neurotechnology Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurotechnology Device industry.

This Insight Report provides a comprehensive analysis of the global Neurotechnology Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurotechnology Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurotechnology Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurotechnology Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurotechnology Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurotechnology Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Neuroprosthetics
Neural Stimulators
Neurorehabilitation
Neurosensing

Segmentation by application
Parkinson's Disease
Cerebral Palsy
Cognitive Disorders
Epilepsy
Incontinence
Traumatic Brain Injury
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Advanced Bionics
Axonics Modulation Technologies
Boston Scientific Corp
Laborie
Cleveland Medical Devices
EndoStim
LivaNova
Medtronic
Natus Medical Incorporated
Neuronetics
NeuroSigma
Restorative Therapies
Zynex Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neurotechnology Device market?

What factors are driving Neurotechnology Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neurotechnology Device market opportunities vary by end market size?

How does Neurotechnology Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.